Atomfair

Awaiting product image

Atomfair Cabergoline C26H37N5O2 CAS 81409-90-7

Cabergoline (CAS 81409-90-7) – High-Purity Dopamine Agonist for Research and Pharmaceutical Applications Molecular Formula: C26H37N5O2Synonyms: Dostinex, Cabaser, FCE-21336, and others (see full list). Description: Cabergoline is a synthetic ergot derivative with potent dopamine D2receptor agonist properties. This high-purity compound (≥98% by HPLC) is widely used in neurological, endocrinological, and veterinary research due to its long-acting inhibition of prolactin secretion. Key Features: High Purity: Manufactured under strict GMP conditions for reliable results. Long Half-Life: Extended duration of action compared to other dopamine agonists. Research Applications: Ideal for studying hyperprolactinemia, Parkinson’s disease, and reproductive disorders. Packaging: Available in 1mg, 5mg, 10mg, and…

Category:

Description

Cabergoline (CAS 81409-90-7) – High-Purity Dopamine Agonist for Research and Pharmaceutical Applications

Molecular Formula: C26H37N5O2

Synonyms: Dostinex, Cabaser, FCE-21336, and others (see full list).

Description: Cabergoline is a synthetic ergot derivative with potent dopamine D2 receptor agonist properties. This high-purity compound (≥98% by HPLC) is widely used in neurological, endocrinological, and veterinary research due to its long-acting inhibition of prolactin secretion.

Key Features:

  • High Purity: Manufactured under strict GMP conditions for reliable results.
  • Long Half-Life: Extended duration of action compared to other dopamine agonists.
  • Research Applications: Ideal for studying hyperprolactinemia, Parkinson’s disease, and reproductive disorders.

Packaging: Available in 1mg, 5mg, 10mg, and 25mg quantities. Custom packaging available upon request.

Storage: Store at 2-8°C in a tightly sealed container, protected from light and moisture.

Properties

  • CAS Number: 81409-90-7
  • Complexity: 713
  • IUPAC Name: (6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
  • InChI: InChI=1S/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1
  • InChI Key: KORNTPPJEAJQIU-KJXAQDMKSA-N
  • Exact Mass: 451.29472544
  • Molecular Formula: C26H37N5O2
  • Molecular Weight: 451.6
  • SMILES: CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C
  • Topological: 71.7
  • Monoisotopic Mass: 451.29472544
  • Physical Description: Solid
  • Melting Point: 102-104 °C
  • Solubility: Insoluble
  • Synonyms: cabergoline, 81409-90-7, Cabergolina, Cabergolinum, Cabergolinum [Latin], Velactis, Caberlin, UNII-LL60K9J05T, 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea, BRN 6020775, CHEBI:3286, LL60K9J05T, DTXSID6022719, DTXCID502719, Cabergoline [USAN:USP:INN:BAN], 1-ethyl-3-(3′-dimethylamionpropyl)-2-(6′-allylergoline-8’beta-carbonyl)urea, Cabergolinum (Latin), 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea, (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide, CABERGOLINE (MART.), CABERGOLINE [MART.], CABERGOLINE (USP-RS), CABERGOLINE [USP-RS], (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide, Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-, (8-beta)-, Ergoline-8beta-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-, CABERGOLINE (EP MONOGRAPH), CABERGOLINE [EP MONOGRAPH], CABERGOLINE (USP MONOGRAPH), CABERGOLINE [USP MONOGRAPH], Cabergoline (USAN:USP:INN:BAN), CABERGOLINE (EMA EPAR VETERINARY), CABERGOLINE [EMA EPAR VETERINARY], (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide, (8R)-6-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)ergoline-8-carboxamide, 1-((6-allylergoline-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea, 1-[(6-allylergolin-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea, (8beta)-N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-ergoline-8-carboxamide, (8beta)-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide, G02CB03, N04BC06, Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propen-1-yl)-, (8beta)-, Dostinex, Cabaser, Cabergolina [Spanish], FCE-21336, FCE 21336, Cabaseril, MFCD00867887, (6aR,9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide, Sogilen, Dostinex (TN), (6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide, 1-[3-(dimethylamino)propyl]-3-ethyl-1-{[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]carbonyl}urea, Cabaser (TN), CAS-81409-90-7, SR-05000001493, NCGC00167821-01, Cabergoline; 1-Ethyl-3-[3-(dimethylamino)propyl]-3-[[(6aR,9R,10aR)-7-(prop-2-enyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]carbonyl]urea, CG-101, Cabergoline (Standard), CABERGOLINE [MI], CABERGOLINE [INN], CABERGOLINE [JAN], CABERGOLINE [USAN], GTPL37, CABERGOLINE [VANDF], SCHEMBL42292, CABERGOLINE [WHO-DD], BIDD:GT0775, Cabergoline (JP18/USP/INN), CHEMBL1201087, Cabergoline, >=98% (HPLC), CABERGOLINE [ORANGE BOOK], Cabergoline;FCE-21336;Cabaser, MSK1661, KORNTPPJEAJQIU-KJXAQDMKSA-N, HMS2090A09, HMS3886H05, Tox21_112589, BDBM50426497, HY-15296R, s5842, 1-Ethyl-3-(3′-dimethylaminopropyl)-3-(6′-allylergoline-8’beta-carbonyl)urea, AKOS015961587, Tox21_112589_1, DB00248, FD19622, NCGC00344544-01, (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-prop-2-en-1-ylergoline-8-carboxamide, AC-26126, HY-15296, MS-28208, Cabergoline 1000 microg/mL in Acetonitrile, NS00001091, C08187, D00987, F17353, AB01275484-01, EN300-19767804, Q423308, SR-05000001493-1, SR-05000001493-2, BRD-K86882815-001-01-6, BRD-K86882815-001-03-2, Cabergoline, European Pharmacopoeia (EP) Reference Standard, Cabergoline, United States Pharmacopeia (USP) Reference Standard, 1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)-propyl]-3-ethylurea, 6-allyl-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-ergoline-8beta-carboxamide, N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-allyl-ergoline-8beta-carboxamide, (8?)-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl] -6-(2-propen-1-yl)-ergoline-8-carboxamide, 1-[3-(dimethylamino)propyl]-3-ethyl-1-[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carbonyl]urea, ERGOLINE-8.BETA.-CARBOXAMIDE, N-(3-(DIMETHYLAMINO)PROPYL)-N-((ETHYLAMINO)CARBONYL)-6-(2-PROPENYL)-

Cabergoline is primarily used in research settings to study prolactin-secreting adenomas due to its potent dopamine D2 receptor agonist activity. It has applications in veterinary medicine for managing pseudopregnancy in dogs. Researchers also utilize Cabergoline to investigate its effects on Parkinson’s disease and other dopamine-related disorders. Its long half-life makes it particularly useful for chronic studies requiring sustained dopaminergic stimulation.

Safety and Hazards

GHS Hazard Statements

  • H302 (97.8%): Harmful if swallowed [Warning Acute toxicity, oral]
  • H315 (84.8%): Causes skin irritation [Warning Skin corrosion/irritation]
  • H319 (82.6%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
  • H335 (82.6%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]

Precautionary Statements

  • P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501

Hazard Classes and Categories

  • Acute Tox. 4 (97.8%)
  • Skin Irrit. 2 (84.8%)
  • Eye Irrit. 2 (82.6%)
  • STOT SE 3 (82.6%)

If you are interested or have any questions, please contact us at support@atomfair.com

Disclaimer: Sold exclusively for laboratory research. Prohibited for commercial use, diagnostics, or human/animal applications. Buyers assume all compliance liability.

Disclaimer

Intended Use & Restrictions

This product is sold exclusively for laboratory research, analytical testing, or non-commercial purposes.

  • Strictly prohibited: Resale, repackaging, or formulation into commercial products.
  • Not approved for human/animal use, diagnostics, or manufacturing (including pharmaceuticals, agrochemicals, or consumer goods).

Patent & Regulatory Compliance

Certain molecules may be protected by active patents or regulatory restrictions.

  • Buyers must independently verify patent status (e.g., via USPTO/EPO/CNIPA) and comply with local laws.
  • Atomfair LLC does not provide legal assurances regarding patent non-infringement or jurisdictional compliance.

Liability Release

By purchasing, the buyer agrees to:

  • Use this product only as permitted by law.
  • Indemnify Atomfair LLC against all claims arising from misuse, patent infringement, or regulatory violations.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Related products